SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-061609
Filing Date
2024-05-15
Accepted
2024-05-15 08:05:18
Documents
15
Period of Report
2024-05-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2414482d1_8k.htm   iXBRL 8-K 28947
2 EXHIBIT 99.1 tm2414482d1_ex99-1.htm EX-99.1 50860
6 GRAPHIC tm2414482d1_ex99-1img001.gif GRAPHIC 3276
  Complete submission text file 0001104659-24-061609.txt   267927

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sgmt-20240515.xsd EX-101.SCH 3012
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sgmt-20240515_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sgmt-20240515_pre.xml EX-101.PRE 22357
18 EXTRACTED XBRL INSTANCE DOCUMENT tm2414482d1_8k_htm.xml XML 3815
Mailing Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402
Business Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402 (650) 561-8600
Sagimet Biosciences Inc. (Filer) CIK: 0001400118 (see all company filings)

IRS No.: 205991472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41742 | Film No.: 24947256
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)